{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:25:34Z","timestamp":1795026334629,"version":"4.10.2"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aims to comprehensively analyze the independent risk factors of postherpetic neuralgia (PHN) through a systematic evaluation, including demographic characteristics, clinical manifestations, treatment regimens, comorbidities, and virological factors, in order to provide evidence-based support for the early identification of high-risk patients and the optimization of preventive strategies in clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A systematic search of PubMed, Embase, and the Cochrane Library was conducted to identify studies reporting risk factors for PHN. After screening the literature according to predefined inclusion and exclusion criteria, effect size indicators such as odds ratios (OR) and 95% confidence intervals (95% CI) for each risk factor were extracted. Meta-analyses were performed using RevMan 5.4 and Stata 15.0 software, with a random-effects model applied to pool effect sizes. Publication bias was assessed using Egger\u2019s test, and sensitivity analysis was conducted by sequentially removing individual studies to verify the robustness of the result.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Age (\u226560 years), severe rash manifestations, prodromal pain symptoms, smoking history, alcohol abuse, immunosuppressive status, and comorbidities including diabetes mellitus, chronic obstructive pulmonary disease (COPD), hypertension, malignant tumors, or chronic kidney disease, along with high viral load, have been identified as independent risk factors for the development of PHN(p&amp;lt;0.05). In contrast, gender differences and socioeconomic status were not significantly associated with PHN incidence, with insufficient evidence observed (I\u00b2&amp;gt;50%, p&amp;gt;0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This meta-analysis confirms that older age (\u226560 years), severe rash, prodromal pain, immunosuppressive therapy, and smoking are significant risk factors for PHN. Furthermore, it identifies alcohol abuse, T2DM, COPD, hypertension, cancer, high pain scores (as measured by VAS or NRS), and high HZ viral load as additional risk factors. COVID-19 may represent a potential risk factor that must be further investigated. The association between socioeconomic status and PHN remains inconclusive, while antibody levels against varicella-zoster virus (VZV) may serve as a protective factor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:uri>https:\/\/www.crd.york.ac.uk\/PROSPERO\/<\/jats:uri>\n                      , identifier CRD42025629699.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1667364","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:52:25Z","timestamp":1759297945000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Risk factors for postherpetic neuralgia: a meta-analysis based on demographic, clinical features, and treatment characteristics"],"prefix":"10.3389","volume":"16","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoya","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjie","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-7568(22)00039-3","article-title":"Post-licensure zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in older adults: a systematic review and meta-analysis","volume":"3","author":"Mbinta","year":"2022","journal-title":"Lancet Healthy Longev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"107181","DOI":"10.1016\/j.ijid.2024.107181","article-title":"Association of the incidence of postherpetic neuralgia with early treatment intervention of herpes zoster and patient baseline characteristics: A systematic review and meta-analysis of cohort studies","volume":"147","author":"Ding","year":"2024","journal-title":"Int J Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/j.pain.0000000000000307","article-title":"A systematic review and meta-analysis of risk factors for postherpetic neuralgia","volume":"157","author":"Forbes","year":"2016","journal-title":"Pain"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.21037\/apm-21-3028","article-title":"A systematic review and meta-analysis of independent risk factors for postherpetic neuralgia","volume":"10","author":"Zhou","year":"2021","journal-title":"Ann Palliat Med"},{"key":"B6","article-title":"A nomogram model for predicting postherpetic neuralgia in patients with herpes zoster: A prospective study","volume":"27","author":"Hu","year":"2024","journal-title":"Pain Physician"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.06.016","article-title":"A population based study of the epidemiology of Herpes Zoster and its complications","volume":"67","author":"Weitzman","year":"2013","journal-title":"J Infect"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1159\/000500482","article-title":"Analysis of the risk factors for postherpetic neuralgia","volume":"235","author":"Wei","year":"2019","journal-title":"Dermatology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2346310","DOI":"10.1080\/13685538.2024.2346310","article-title":"Associations between organic erectile dysfunction and the risk of herpes zoster and postherpetic neuralgia in men","volume":"27","author":"Wang","year":"2024","journal-title":"Aging Male"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13639","article-title":"Burden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older: Results from an observational, prospective, physician practice-based cohort study","volume":"44","author":"Sato","year":"2017","journal-title":"J Dermatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0000000000000937","article-title":"Circulating level of myelin basic protein predicts postherpetic neuralgia: A prospective study","volume":"37","author":"Yang","year":"2021","journal-title":"Clin J Pain"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21254","article-title":"Clinical and psychosocial correlates of post-herpetic neuralgia","volume":"80","author":"Volpi","year":"2008","journal-title":"J Med Virol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/19.5.471","article-title":"Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database","volume":"19","author":"Opstelten","year":"2002","journal-title":"Fam Pract"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.02.001","article-title":"Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged \u226550 years: A prospective study","volume":"76","author":"Schmidt-Ott","year":"2018","journal-title":"J Infect"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.02.004","article-title":"Predicting postherpetic neuralgia in elderly primary care patients with herpes zoster: prospective prognostic study","author":"Opstelten","year":"2007","journal-title":"Pain"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2015.03.022","article-title":"Predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from North and Latin America and Asia","volume":"34","author":"Kawai","year":"2015","journal-title":"Int J Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2005.07.006","article-title":"Psychosocial risk factors for postherpetic neuralgia: a prospective study of patients with herpes zoster","volume":"6","author":"Katz","year":"2005","journal-title":"J Pain"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002808","article-title":"Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort study","volume":"87","author":"Forbes","year":"2016","journal-title":"Neurology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112137-20220601-01213","article-title":"Study of risk factors of postherpetic neuralgia","volume":"102","author":"Hu","year":"2022","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1002\/jmv.25543","article-title":"Relationships of varicella zoster virus (VZV)-specific cell-mediated immunity and persistence of VZV DNA in saliva and the development of postherpetic neuralgia in patients with herpes zoster","volume":"91","author":"Park","year":"2019","journal-title":"J Med Virol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24051","article-title":"Peptic ulcer as a risk factor for postherpetic neuralgia in adult patients with herpes zoster","volume":"87","author":"Chen","year":"2015","journal-title":"J Med Virol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.36076\/ppj.2023.26.E397","article-title":"Analysis of risk factors for postherpetic neuralgia in patients with postmalignancy herpes zoster","volume":"26","author":"Li","year":"2023","journal-title":"Pain Physician"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/nu12082384","article-title":"Plasma vitamin C concentrations were negatively associated with tingling, prickling or pins and needles sensation in patients with postherpetic neuralgia","volume":"12","author":"Wang","year":"2020","journal-title":"Nutrients"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.04.004","article-title":"Impact of postherpetic neuralgia: A six year population-based analysis on people aged 50 years or older","volume":"77","author":"Mu\u00f1oz-Quiles","year":"2018","journal-title":"J Infect"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2010.02.020","article-title":"Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study","volume":"11","author":"Drolet","year":"2010","journal-title":"J Pain"},{"key":"B26","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12879-017-2416-7","article-title":"A case control study on family history as a risk factor for herpes zoster and associated outcomes, Beijing, China","volume":"17","author":"Suo","year":"2017","journal-title":"BMC Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/papr.12766","article-title":"Sleep shortage is associated with postherpetic neuralgia development through hyperesthesia and acute pain intensity: A community-based prospective cohort study","volume":"19","author":"Yamada","year":"2019","journal-title":"Pain Pract"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2003.10.027","article-title":"Cerebrospinal fluid interleukin 8 concentrations and the subsequent development of postherpetic neuralgia","volume":"116","author":"Kotani","year":"2004","journal-title":"Am J Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2013.10.006","article-title":"Use of S-LANSS, a tool for screening neuropathic pain, for predicting postherpetic neuralgia in patients after acute herpes zoster events: a single-center, 12-month, prospective cohort study","volume":"15","author":"Cho","year":"2014","journal-title":"J Pain"},{"key":"B30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1741-7015-8-58","article-title":"Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapy","volume":"8","author":"Parruti","year":"2010","journal-title":"BMC Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"8730918","DOI":"10.1155\/2020\/8730918","article-title":"Correlation between galectin-3 and early herpes zoster neuralgia and postherpetic neuralgia: A retrospective clinical observation","volume":"2020","author":"Wang","year":"2020","journal-title":"Pain Res Manage"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e4577","DOI":"10.1097\/MD.0000000000004577","article-title":"Efficacy of continuous epidural block in acute herpes zoster: Incidence and predictive factors of postherpetic neuralgia, a retrospective single-center study","volume":"95","author":"Kim","year":"2016","journal-title":"Med (Baltimore)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/nu11112787","article-title":"Hypovitaminosis din postherpetic neuralgia-high prevalence and inverse association with pain: A retrospective study","volume":"11","author":"Chen","year":"2019","journal-title":"Nutrients"},{"key":"B34","doi-asserted-by":"publisher","first-page":"126451","DOI":"10.1016\/j.vaccine.2024.126451","article-title":"The risk of postherpetic neuralgia in COVID-19 vaccination-associated herpes zoster: A retrospective cohort study using TriNetX","volume":"42","author":"Ma","year":"2024","journal-title":"Vaccine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1152\/physrev.00045.2019","article-title":"Neuropathic pain: from mechanisms to treatment","volume":"101","author":"Finnerup","year":"2021","journal-title":"Physiol Rev"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-023-01146-x","article-title":"Therapeutic strategies for postherpetic neuralgia: mechanisms, treatments, and perspectives","volume":"27","author":"Tang","year":"2023","journal-title":"Curr Pain Headache Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/j.pain.0000000000001122","article-title":"Inflammation in the pathophysiology of neuropathic pain","volume":"159","author":"Sommer","year":"2018","journal-title":"Pain"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/srt.13867","article-title":"Peripheral and central pathogenesis of postherpetic neuralgia","volume":"30","author":"Liu","year":"2024","journal-title":"Skin Res Technol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3344\/kjp.2021.34.4.463","article-title":"Immunological mechanism of postherpetic neuralgia and effect of pregabalin treatment on the mechanism: a prospective single-arm observational study","volume":"34","author":"Mercan","year":"2021","journal-title":"Korean J Pain"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1667364\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:52:27Z","timestamp":1759297947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1667364\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":39,"alternative-id":["10.3389\/fimmu.2025.1667364"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1667364","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2025.1667364.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2025.1667364.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2025.1667364.s003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2025.1667364.s004","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2025.1667364.s005","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"article-number":"1667364"}}